NEW YORK, May 25 (GenomeWeb News) - Invitrogen, with two acquisitions already under its belt this year, has done it again.

The Carlsbad, Calif.-based company has purchased the assets of microarray maker Xeotron of Houston, Texas, for an undisclosed sum, the company confirmed today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.